Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The investigators seek to demonstrate that the combined use of cilostazol and nimodipine will
significantly decrease the rate of delayed cerebral infarction and cerebral vasospasm after
cerebrovascular intervention when compared to nimodipine alone.